Patient Square has purchased 210,000 shares of Nektar Pharmaceuticals (NKTR), indicating a significant investment move. This purchase reflects Patient Square's confidence in Nektar's future prospects and potential growth. Investors may view this as a positive signal for Nektar's stock performance going forward.
Toescoin, a meme coin on the Solana blockchain, is expanding its public website and social media presence to grow its community. The project emphasizes meme culture, humor, and online identity rather than traditional utility, aiming to increase parti...
Following President Trump's announcement of a US-Iran peace agreement, markets now see a 77% probability of a US-Iran nuclear deal before 2027, up from 64% the day before. The likelihood of Iran surrendering its enriched uranium stockpile by the end ...
All In FutureTech Alliance (AGAE) announced it will acquire a 57.67% controlling stake in HyalRoute, a leading Southeast Asian fiber-optic infrastructure company, by issuing new shares priced at $10 each. The deal values HyalRoute at $4 billion and m...
Hyperliquid's HYPE token recently hit an all-time high, driven largely by the protocol's mechanism that funnels nearly all trading fees into buying back HYPE tokens. This continuous buyback, embedded in the protocol, supports the token price independ...
Bitcoin has struggled to break above $80,000 after 12 days of consolidation, with an eight-month deleveraging cycle now slowing. Open Interest in perpetual markets rose from $6.4 billion to $8.96 billion since March, indicating renewed trader activit...
